Studies on CD₄⁺CD₂₅+FOXP3⁺regulatory T Cells in Patients with Graves’ Disease and Patients with Rheumatoid Arthritis

Abstract

Related Dissertations

1. Changes of Serum Fibroblast Growth Factor 21 Levels in Graves Disease and Its Influence Factors,R581.1
2. Graves' disease and symptoms of major pathogenic mood , syndrome distribution of clinical epidemiology,R259
3. Graves disease personality traits, coping style and mood -prone multiple linear regression analysis,R581.1
4. Study of Thyroid Hormone Levels in Patients with Hyperthyroidism Who Received Only ¹³¹I Therapy and Glucocorticoid Following ¹³¹I Therapy,R581.1
5. The Pathological Study on Expression of CK-19、VEGF-C、COX-2 and Vimentin in Grave’s Disease and Hashimoto’s Thyroiditis and the Detection of ER and PR mRNA in Hashimoto’s Thyroiditis,R581.4
6. Discussion about the Correlation of PGE1 with CD and Observation on the Treatment of GD by the Method of Clearing Liver Heart and Reducing Fire,R259
7. The Association Between HLA-DRB1 Alleles Polymorphism, ANCA and Susceptibility To Antithyroid Drug Induced Leucocytopenia in Patients with Graves Disease,R581.1
8. Observation of Malondialdehyde, Myeloperoxidase and Antioxidative Indicatrixes in Serum of Patients with Graves Disease,R581.1
9. Correlational Study of Effect of Graves’ Disease Treated with ¹³¹I and the Serum of Cytokines,R581.1
10. Professor Zhang Lan Experience in the treatment of Graves' disease,R259
11. CD40 gene 5 'untranslated region _1 loci C / T polymorphism with Graves' disease after discontinuation of drug therapy Recurrence,R581.1
12. Graves disease Th1/Th2 imbalance chemokines preliminary study,R581.1
13. Graves \\ ' patient serum CD40 and its ligand (CD40L) The relationship between the level and disease,R581.1
14. UGRP1 gene polymorphism with Graves' disease Kazak Correlation,R581
15. The Professor Li Xiaojuan treatment of Graves' disease Experience,R259
16. Expression of NCR Clear Factor Kappa B and Tumor Necrosis Factor-α in Peripheral Blood Associated with Thyroid Associated Ophthalmopathy,R581
17. The Correlation between the Drift Rate of Serum IL-2/IL-6 and Thyroid Iodine-131 Turnover Rate in Patients with Graves Disease,R581.1
18. Gender-related Differences in Patients with Graves’ Disease,R581.1
19. The Relationship between Iodine Conversion Rate and Therapeutic Efficacy of Radioactive Iodine Therapy,R581.1
20. A Role for Serum Concentration of CXC Chemokine Ligand-10 in Graves Disease,R581.1